{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "train_df = pd.read_csv('/Users/rahul/Desktop/Nexus_Datasets/train.csv')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "##### ID: Unique identifier for each entry.\n",
    "##### TargetID: Identifier for the target.\n",
    "##### DRUGID: Unique identifier for the drug.\n",
    "##### DRUGTYPE: Type of drug (e.g., small molecular drug). \n",
    "##### Drug_high_status: Approval status of the drug (e.g., Approved).\n",
    "##### DRUGNAME: Name of the drug.\n",
    "##### PUBCHCID: PubChem compound ID.\n",
    "##### Disease_of_highest_status: Disease associated with the highest status.\n",
    "##### Drug_Status: Status of the drug in the dataset.\n",
    "##### UNIPROID: UniProt identifier for the target protein.\n",
    "##### TARGNAME: Name of the target.\n",
    "##### GENENAME: Gene name associated with the target.\n",
    "##### SYNONYMS: Alternate names for the target.\n",
    "##### FUNCTION: Biological function of the target.\n",
    "##### BIOCLASS: Biological classification of the target.\n",
    "##### SEQUENCE: Amino acid sequence of the target protein.\n",
    "##### Disease: Disease associated with the drug.\n",
    "##### Accession Number: Accession number in relevant databases.\n",
    "##### Target_Status: Current status of the target (e.g., Approved).\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>TargetID</th>\n",
       "      <th>DRUGID</th>\n",
       "      <th>DRUGTYPE</th>\n",
       "      <th>Drug_high_status</th>\n",
       "      <th>DRUGNAME</th>\n",
       "      <th>PUBCHCID</th>\n",
       "      <th>Disease_of_highest_status</th>\n",
       "      <th>Drug_Status</th>\n",
       "      <th>UNIPROID</th>\n",
       "      <th>TARGNAME</th>\n",
       "      <th>GENENAME</th>\n",
       "      <th>SYNONYMS</th>\n",
       "      <th>FUNCTION</th>\n",
       "      <th>BIOCLASS</th>\n",
       "      <th>SEQUENCE</th>\n",
       "      <th>Disease</th>\n",
       "      <th>Accession Number</th>\n",
       "      <th>Target_Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>140736</td>\n",
       "      <td>T51115</td>\n",
       "      <td>D0L4YD</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Solifenacin</td>\n",
       "      <td>154059</td>\n",
       "      <td>Overactive bladder</td>\n",
       "      <td>Approved</td>\n",
       "      <td>CAC1C_HUMAN</td>\n",
       "      <td>Voltage-gated calcium channel alpha Cav1.2 (CA...</td>\n",
       "      <td>CACNA1C</td>\n",
       "      <td>Voltage-gated calcium channel subunit alpha Ca...</td>\n",
       "      <td>Mediates influx of calcium ions into the cytop...</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...</td>\n",
       "      <td>Genetic cardiac arrhythmia</td>\n",
       "      <td>Q13936</td>\n",
       "      <td>Terminated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>133048</td>\n",
       "      <td>T60529</td>\n",
       "      <td>D03NMM</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Investigative</td>\n",
       "      <td>AM-643</td>\n",
       "      <td>46843035</td>\n",
       "      <td>Dermatological disease</td>\n",
       "      <td>Investigative</td>\n",
       "      <td>PGH1_HUMAN</td>\n",
       "      <td>Prostaglandin G/H synthase 1 (COX-1)</td>\n",
       "      <td>PTGS1</td>\n",
       "      <td>Prostaglandin-endoperoxide synthase 1; Prostag...</td>\n",
       "      <td>Converts arachidonate to prostaglandin H2 (PGH...</td>\n",
       "      <td>Paired donor oxygen oxidoreductase</td>\n",
       "      <td>MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...</td>\n",
       "      <td>Rheumatoid arthritis</td>\n",
       "      <td>P23219</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>60493</td>\n",
       "      <td>T80975</td>\n",
       "      <td>D0T2ER</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>TAK-593</td>\n",
       "      <td>24767976</td>\n",
       "      <td>Solid tumour/cancer</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>VGFR2_HUMAN</td>\n",
       "      <td>Vascular endothelial growth factor receptor 2 ...</td>\n",
       "      <td>KDR</td>\n",
       "      <td>VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...</td>\n",
       "      <td>Plays an essential role in the regulation of a...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...</td>\n",
       "      <td>Renal cell carcinoma</td>\n",
       "      <td>P35968</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>169176</td>\n",
       "      <td>T92072</td>\n",
       "      <td>D07ESH</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Discontinued in Phase 3</td>\n",
       "      <td>PF-1913539</td>\n",
       "      <td>176408</td>\n",
       "      <td>Alzheimer disease</td>\n",
       "      <td>Discontinued in Phase 3</td>\n",
       "      <td>AA1R_HUMAN</td>\n",
       "      <td>Adenosine A1 receptor (ADORA1)</td>\n",
       "      <td>ADORA1</td>\n",
       "      <td>Adenosine receptor A1; A(1) adenosine receptor</td>\n",
       "      <td>The activity of this receptor is mediated by G...</td>\n",
       "      <td>GPCR rhodopsin</td>\n",
       "      <td>MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...</td>\n",
       "      <td>Hyper-lipoproteinaemia</td>\n",
       "      <td>P30542</td>\n",
       "      <td>Phase 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>120183</td>\n",
       "      <td>T30082</td>\n",
       "      <td>D0Q0RC</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Ethopropazine</td>\n",
       "      <td>3290</td>\n",
       "      <td>Parkinson disease</td>\n",
       "      <td>Approved</td>\n",
       "      <td>ACES_HUMAN</td>\n",
       "      <td>Acetylcholinesterase (AChE)</td>\n",
       "      <td>ACHE</td>\n",
       "      <td>YT; N-ACHE; ARACHE</td>\n",
       "      <td>Role in neuronal apoptosis. Terminates signal ...</td>\n",
       "      <td>Carboxylic ester hydrolase</td>\n",
       "      <td>MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...</td>\n",
       "      <td>Oesophageal/gastroduodenal disorder</td>\n",
       "      <td>P22303</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>137655</td>\n",
       "      <td>T75243</td>\n",
       "      <td>D0W7HE</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Alpelisib</td>\n",
       "      <td>56649450</td>\n",
       "      <td>Solid tumour/cancer</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>MTOR_HUMAN</td>\n",
       "      <td>Serine/threonine-protein kinase mTOR (mTOR)</td>\n",
       "      <td>MTOR</td>\n",
       "      <td>Target of rapamycin; TOR kinase; Rapamycin tar...</td>\n",
       "      <td>MTOR directly or indirectly regulates the phos...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQH...</td>\n",
       "      <td>Bladder cancer</td>\n",
       "      <td>P42345</td>\n",
       "      <td>Phase 1/2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>86935</td>\n",
       "      <td>T85435</td>\n",
       "      <td>D0O0LS</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Entrectinib</td>\n",
       "      <td>25141092</td>\n",
       "      <td>Solid tumour/cancer</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>INSR_HUMAN</td>\n",
       "      <td>Insulin receptor (INSR)</td>\n",
       "      <td>INSR</td>\n",
       "      <td>IR; CD220 antigen; CD220</td>\n",
       "      <td>Binding of insulin leads to phosphorylation of...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MATGGRRGAAAAPLLVAVAALLLGAAGHLYPGEVCPGMDIRNNLTR...</td>\n",
       "      <td>Acute diabete complication</td>\n",
       "      <td>P06213</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>96089</td>\n",
       "      <td>T40954</td>\n",
       "      <td>D0N0ES</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Vitamin B3</td>\n",
       "      <td>938</td>\n",
       "      <td>Lipid metabolism disorder</td>\n",
       "      <td>Approved</td>\n",
       "      <td>XDH_HUMAN</td>\n",
       "      <td>Xanthine dehydrogenase/oxidase (XDH)</td>\n",
       "      <td>XDH</td>\n",
       "      <td>Xanthine oxidase; Xanthine dehydrogenase; XDHA</td>\n",
       "      <td>Catalyzes the oxidation of hypoxanthine to xan...</td>\n",
       "      <td>CH/CH(2) oxidoreductase</td>\n",
       "      <td>MTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEG...</td>\n",
       "      <td>Encephalopathy</td>\n",
       "      <td>P47989</td>\n",
       "      <td>Phase 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>142033</td>\n",
       "      <td>T21945</td>\n",
       "      <td>D04PXS</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>Amitifadine</td>\n",
       "      <td>11658655</td>\n",
       "      <td>Mood disorder</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>SC6A2_HUMAN</td>\n",
       "      <td>Norepinephrine transporter (NET)</td>\n",
       "      <td>SLC6A2</td>\n",
       "      <td>Solute carrier family 6 member 2; Sodium-depen...</td>\n",
       "      <td>Amine transporter. Terminates the action of no...</td>\n",
       "      <td>Neurotransmitter:sodium symporter</td>\n",
       "      <td>MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLL...</td>\n",
       "      <td>Pain</td>\n",
       "      <td>P23975</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>25065</td>\n",
       "      <td>T78709</td>\n",
       "      <td>D0P2QO</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>S-15535</td>\n",
       "      <td>132787</td>\n",
       "      <td>Anxiety disorder</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>5HT1A_HUMAN</td>\n",
       "      <td>5-HT 1A receptor (HTR1A)</td>\n",
       "      <td>HTR1A</td>\n",
       "      <td>Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1...</td>\n",
       "      <td>Functions as a receptor for various drugs and ...</td>\n",
       "      <td>GPCR rhodopsin</td>\n",
       "      <td>MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTL...</td>\n",
       "      <td>Attention deficit hyperactivity disorder</td>\n",
       "      <td>P08908</td>\n",
       "      <td>Phase 3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "       ID TargetID  DRUGID              DRUGTYPE         Drug_high_status  \\\n",
       "0  140736   T51115  D0L4YD  Small molecular drug                 Approved   \n",
       "1  133048   T60529  D03NMM  Small molecular drug            Investigative   \n",
       "2   60493   T80975  D0T2ER  Small molecular drug                  Phase 1   \n",
       "3  169176   T92072  D07ESH  Small molecular drug  Discontinued in Phase 3   \n",
       "4  120183   T30082  D0Q0RC  Small molecular drug                 Approved   \n",
       "5  137655   T75243  D0W7HE  Small molecular drug                 Approved   \n",
       "6   86935   T85435  D0O0LS  Small molecular drug                 Approved   \n",
       "7   96089   T40954  D0N0ES  Small molecular drug                 Approved   \n",
       "8  142033   T21945  D04PXS  Small molecular drug                  Phase 3   \n",
       "9   25065   T78709  D0P2QO  Small molecular drug                  Phase 2   \n",
       "\n",
       "        DRUGNAME  PUBCHCID  Disease_of_highest_status  \\\n",
       "0    Solifenacin    154059         Overactive bladder   \n",
       "1         AM-643  46843035     Dermatological disease   \n",
       "2        TAK-593  24767976        Solid tumour/cancer   \n",
       "3     PF-1913539    176408          Alzheimer disease   \n",
       "4  Ethopropazine      3290          Parkinson disease   \n",
       "5      Alpelisib  56649450        Solid tumour/cancer   \n",
       "6    Entrectinib  25141092        Solid tumour/cancer   \n",
       "7     Vitamin B3       938  Lipid metabolism disorder   \n",
       "8    Amitifadine  11658655              Mood disorder   \n",
       "9        S-15535    132787           Anxiety disorder   \n",
       "\n",
       "               Drug_Status     UNIPROID  \\\n",
       "0                 Approved  CAC1C_HUMAN   \n",
       "1            Investigative   PGH1_HUMAN   \n",
       "2                  Phase 1  VGFR2_HUMAN   \n",
       "3  Discontinued in Phase 3   AA1R_HUMAN   \n",
       "4                 Approved   ACES_HUMAN   \n",
       "5                  Phase 2   MTOR_HUMAN   \n",
       "6                  Phase 2   INSR_HUMAN   \n",
       "7                 Approved    XDH_HUMAN   \n",
       "8                  Phase 2  SC6A2_HUMAN   \n",
       "9                  Phase 2  5HT1A_HUMAN   \n",
       "\n",
       "                                            TARGNAME GENENAME  \\\n",
       "0  Voltage-gated calcium channel alpha Cav1.2 (CA...  CACNA1C   \n",
       "1               Prostaglandin G/H synthase 1 (COX-1)    PTGS1   \n",
       "2  Vascular endothelial growth factor receptor 2 ...      KDR   \n",
       "3                     Adenosine A1 receptor (ADORA1)   ADORA1   \n",
       "4                        Acetylcholinesterase (AChE)     ACHE   \n",
       "5        Serine/threonine-protein kinase mTOR (mTOR)     MTOR   \n",
       "6                            Insulin receptor (INSR)     INSR   \n",
       "7               Xanthine dehydrogenase/oxidase (XDH)      XDH   \n",
       "8                   Norepinephrine transporter (NET)   SLC6A2   \n",
       "9                           5-HT 1A receptor (HTR1A)    HTR1A   \n",
       "\n",
       "                                            SYNONYMS  \\\n",
       "0  Voltage-gated calcium channel subunit alpha Ca...   \n",
       "1  Prostaglandin-endoperoxide synthase 1; Prostag...   \n",
       "2  VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...   \n",
       "3     Adenosine receptor A1; A(1) adenosine receptor   \n",
       "4                                 YT; N-ACHE; ARACHE   \n",
       "5  Target of rapamycin; TOR kinase; Rapamycin tar...   \n",
       "6                           IR; CD220 antigen; CD220   \n",
       "7     Xanthine oxidase; Xanthine dehydrogenase; XDHA   \n",
       "8  Solute carrier family 6 member 2; Sodium-depen...   \n",
       "9  Serotonin receptor 1A; G-21; ADRBRL1; ADRB2RL1...   \n",
       "\n",
       "                                            FUNCTION  \\\n",
       "0  Mediates influx of calcium ions into the cytop...   \n",
       "1  Converts arachidonate to prostaglandin H2 (PGH...   \n",
       "2  Plays an essential role in the regulation of a...   \n",
       "3  The activity of this receptor is mediated by G...   \n",
       "4  Role in neuronal apoptosis. Terminates signal ...   \n",
       "5  MTOR directly or indirectly regulates the phos...   \n",
       "6  Binding of insulin leads to phosphorylation of...   \n",
       "7  Catalyzes the oxidation of hypoxanthine to xan...   \n",
       "8  Amine transporter. Terminates the action of no...   \n",
       "9  Functions as a receptor for various drugs and ...   \n",
       "\n",
       "                             BIOCLASS  \\\n",
       "0           Voltage-gated ion channel   \n",
       "1  Paired donor oxygen oxidoreductase   \n",
       "2                              Kinase   \n",
       "3                      GPCR rhodopsin   \n",
       "4          Carboxylic ester hydrolase   \n",
       "5                              Kinase   \n",
       "6                              Kinase   \n",
       "7             CH/CH(2) oxidoreductase   \n",
       "8   Neurotransmitter:sodium symporter   \n",
       "9                      GPCR rhodopsin   \n",
       "\n",
       "                                            SEQUENCE  \\\n",
       "0  MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...   \n",
       "1  MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...   \n",
       "2  MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...   \n",
       "3  MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...   \n",
       "4  MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...   \n",
       "5  MLGTGPAAATTAATTSSNVSVLQQFASGLKSRNEETRAKAAKELQH...   \n",
       "6  MATGGRRGAAAAPLLVAVAALLLGAAGHLYPGEVCPGMDIRNNLTR...   \n",
       "7  MTADKLVFFVNGRKVVEKNADPETTLLAYLRRKLGLSGTKLGCGEG...   \n",
       "8  MLLARMNPQVQPENNGADTGPEQPLRARKTAELLVVKERNGVQCLL...   \n",
       "9  MDVLSPGQGNNTTSPPAPFETGGNTTGISDVTVSYQVITSLLLGTL...   \n",
       "\n",
       "                                    Disease Accession Number Target_Status  \n",
       "0                Genetic cardiac arrhythmia           Q13936    Terminated  \n",
       "1                      Rheumatoid arthritis           P23219      Approved  \n",
       "2                      Renal cell carcinoma           P35968      Approved  \n",
       "3                    Hyper-lipoproteinaemia           P30542       Phase 2  \n",
       "4       Oesophageal/gastroduodenal disorder           P22303      Approved  \n",
       "5                            Bladder cancer           P42345     Phase 1/2  \n",
       "6                Acute diabete complication           P06213      Approved  \n",
       "7                            Encephalopathy           P47989       Phase 2  \n",
       "8                                      Pain           P23975      Approved  \n",
       "9  Attention deficit hyperactivity disorder           P08908       Phase 3  "
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_df.head(10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ID                           0\n",
       "TargetID                     0\n",
       "DRUGID                       0\n",
       "DRUGTYPE                     0\n",
       "Drug_high_status             0\n",
       "DRUGNAME                     0\n",
       "PUBCHCID                     0\n",
       "Disease_of_highest_status    0\n",
       "Drug_Status                  0\n",
       "UNIPROID                     0\n",
       "TARGNAME                     0\n",
       "GENENAME                     0\n",
       "SYNONYMS                     0\n",
       "FUNCTION                     0\n",
       "BIOCLASS                     0\n",
       "SEQUENCE                     0\n",
       "Disease                      0\n",
       "Accession Number             0\n",
       "Target_Status                0\n",
       "dtype: int64"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train_df.isnull().sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "train1_df=train_df.copy()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "ID                            int64\n",
       "TargetID                     object\n",
       "DRUGID                       object\n",
       "DRUGTYPE                     object\n",
       "Drug_high_status             object\n",
       "DRUGNAME                     object\n",
       "PUBCHCID                      int64\n",
       "Disease_of_highest_status    object\n",
       "Drug_Status                  object\n",
       "UNIPROID                     object\n",
       "TARGNAME                     object\n",
       "GENENAME                     object\n",
       "SYNONYMS                     object\n",
       "FUNCTION                     object\n",
       "BIOCLASS                     object\n",
       "SEQUENCE                     object\n",
       "Disease                      object\n",
       "Accession Number             object\n",
       "Target_Status                object\n",
       "dtype: object"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.dtypes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "698"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.SEQUENCE.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index(['ID', 'TargetID', 'DRUGID', 'DRUGTYPE', 'Drug_high_status', 'DRUGNAME',\n",
       "       'PUBCHCID', 'Disease_of_highest_status', 'Drug_Status', 'UNIPROID',\n",
       "       'TARGNAME', 'GENENAME', 'SYNONYMS', 'FUNCTION', 'BIOCLASS', 'SEQUENCE',\n",
       "       'Disease', 'Accession Number', 'Target_Status'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 13,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>TargetID</th>\n",
       "      <th>DRUGID</th>\n",
       "      <th>DRUGTYPE</th>\n",
       "      <th>Drug_high_status</th>\n",
       "      <th>DRUGNAME</th>\n",
       "      <th>PUBCHCID</th>\n",
       "      <th>Disease_of_highest_status</th>\n",
       "      <th>Drug_Status</th>\n",
       "      <th>UNIPROID</th>\n",
       "      <th>TARGNAME</th>\n",
       "      <th>GENENAME</th>\n",
       "      <th>SYNONYMS</th>\n",
       "      <th>FUNCTION</th>\n",
       "      <th>BIOCLASS</th>\n",
       "      <th>SEQUENCE</th>\n",
       "      <th>Disease</th>\n",
       "      <th>Accession Number</th>\n",
       "      <th>Target_Status</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>140736</td>\n",
       "      <td>T51115</td>\n",
       "      <td>D0L4YD</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Solifenacin</td>\n",
       "      <td>154059</td>\n",
       "      <td>Overactive bladder</td>\n",
       "      <td>Approved</td>\n",
       "      <td>CAC1C_HUMAN</td>\n",
       "      <td>Voltage-gated calcium channel alpha Cav1.2 (CA...</td>\n",
       "      <td>CACNA1C</td>\n",
       "      <td>Voltage-gated calcium channel subunit alpha Ca...</td>\n",
       "      <td>Mediates influx of calcium ions into the cytop...</td>\n",
       "      <td>Voltage-gated ion channel</td>\n",
       "      <td>MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...</td>\n",
       "      <td>Genetic cardiac arrhythmia</td>\n",
       "      <td>Q13936</td>\n",
       "      <td>Terminated</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>133048</td>\n",
       "      <td>T60529</td>\n",
       "      <td>D03NMM</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Investigative</td>\n",
       "      <td>AM-643</td>\n",
       "      <td>46843035</td>\n",
       "      <td>Dermatological disease</td>\n",
       "      <td>Investigative</td>\n",
       "      <td>PGH1_HUMAN</td>\n",
       "      <td>Prostaglandin G/H synthase 1 (COX-1)</td>\n",
       "      <td>PTGS1</td>\n",
       "      <td>Prostaglandin-endoperoxide synthase 1; Prostag...</td>\n",
       "      <td>Converts arachidonate to prostaglandin H2 (PGH...</td>\n",
       "      <td>Paired donor oxygen oxidoreductase</td>\n",
       "      <td>MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...</td>\n",
       "      <td>Rheumatoid arthritis</td>\n",
       "      <td>P23219</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>60493</td>\n",
       "      <td>T80975</td>\n",
       "      <td>D0T2ER</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>TAK-593</td>\n",
       "      <td>24767976</td>\n",
       "      <td>Solid tumour/cancer</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>VGFR2_HUMAN</td>\n",
       "      <td>Vascular endothelial growth factor receptor 2 ...</td>\n",
       "      <td>KDR</td>\n",
       "      <td>VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...</td>\n",
       "      <td>Plays an essential role in the regulation of a...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...</td>\n",
       "      <td>Renal cell carcinoma</td>\n",
       "      <td>P35968</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>169176</td>\n",
       "      <td>T92072</td>\n",
       "      <td>D07ESH</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Discontinued in Phase 3</td>\n",
       "      <td>PF-1913539</td>\n",
       "      <td>176408</td>\n",
       "      <td>Alzheimer disease</td>\n",
       "      <td>Discontinued in Phase 3</td>\n",
       "      <td>AA1R_HUMAN</td>\n",
       "      <td>Adenosine A1 receptor (ADORA1)</td>\n",
       "      <td>ADORA1</td>\n",
       "      <td>Adenosine receptor A1; A(1) adenosine receptor</td>\n",
       "      <td>The activity of this receptor is mediated by G...</td>\n",
       "      <td>GPCR rhodopsin</td>\n",
       "      <td>MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...</td>\n",
       "      <td>Hyper-lipoproteinaemia</td>\n",
       "      <td>P30542</td>\n",
       "      <td>Phase 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>120183</td>\n",
       "      <td>T30082</td>\n",
       "      <td>D0Q0RC</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Ethopropazine</td>\n",
       "      <td>3290</td>\n",
       "      <td>Parkinson disease</td>\n",
       "      <td>Approved</td>\n",
       "      <td>ACES_HUMAN</td>\n",
       "      <td>Acetylcholinesterase (AChE)</td>\n",
       "      <td>ACHE</td>\n",
       "      <td>YT; N-ACHE; ARACHE</td>\n",
       "      <td>Role in neuronal apoptosis. Terminates signal ...</td>\n",
       "      <td>Carboxylic ester hydrolase</td>\n",
       "      <td>MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...</td>\n",
       "      <td>Oesophageal/gastroduodenal disorder</td>\n",
       "      <td>P22303</td>\n",
       "      <td>Approved</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134481</th>\n",
       "      <td>147910</td>\n",
       "      <td>T59328</td>\n",
       "      <td>D06WRF</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>KD019</td>\n",
       "      <td>10458325</td>\n",
       "      <td>Meningioma metastases</td>\n",
       "      <td>Phase 2</td>\n",
       "      <td>EGFR_HUMAN</td>\n",
       "      <td>Epidermal growth factor receptor (EGFR)</td>\n",
       "      <td>EGFR</td>\n",
       "      <td>Receptor tyrosine-protein kinase erbB-1; Proto...</td>\n",
       "      <td>Receptor tyrosine kinase binding ligands of th...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFED...</td>\n",
       "      <td>Chronic pain</td>\n",
       "      <td>P00533</td>\n",
       "      <td>Phase 2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134482</th>\n",
       "      <td>37688</td>\n",
       "      <td>T65236</td>\n",
       "      <td>D0WM5O</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Phase 1/2</td>\n",
       "      <td>G1</td>\n",
       "      <td>5322399</td>\n",
       "      <td>Lymphoma</td>\n",
       "      <td>Phase 1/2</td>\n",
       "      <td>GPER1_HUMAN</td>\n",
       "      <td>G-protein coupled estrogen receptor 1 (GPER1)</td>\n",
       "      <td>GPER1</td>\n",
       "      <td>Membrane estrogen receptor; Lymphocyte-derived...</td>\n",
       "      <td>Receptor for estrogen. .</td>\n",
       "      <td>GPCR rhodopsin</td>\n",
       "      <td>MDVTSQARGVGLEMYPGTAQPAAPNTTSPELNLSHPLLGTALANGT...</td>\n",
       "      <td>Lymphoma</td>\n",
       "      <td>Q99527</td>\n",
       "      <td>Phase 1/2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134483</th>\n",
       "      <td>30073</td>\n",
       "      <td>T47768</td>\n",
       "      <td>D04JHN</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Hydromorphone</td>\n",
       "      <td>5284570</td>\n",
       "      <td>Chronic pain</td>\n",
       "      <td>Phase 3</td>\n",
       "      <td>OPRM_HUMAN</td>\n",
       "      <td>Opioid receptor mu (MOP)</td>\n",
       "      <td>OPRM1</td>\n",
       "      <td>hMOP; Mu-type opioid receptor; Mu opioid recep...</td>\n",
       "      <td>Receptor for natural and synthetic opioids inc...</td>\n",
       "      <td>GPCR rhodopsin</td>\n",
       "      <td>MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCG...</td>\n",
       "      <td>Movement disorder</td>\n",
       "      <td>P35372</td>\n",
       "      <td>Investigative</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134484</th>\n",
       "      <td>37855</td>\n",
       "      <td>T40276</td>\n",
       "      <td>D0O0LS</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Approved</td>\n",
       "      <td>Entrectinib</td>\n",
       "      <td>25141092</td>\n",
       "      <td>Mammary analogue secretory carcinoma</td>\n",
       "      <td>Phase 1</td>\n",
       "      <td>KPCB_HUMAN</td>\n",
       "      <td>Protein kinase C beta (PRKCB)</td>\n",
       "      <td>PRKCB</td>\n",
       "      <td>Protein kinase C beta type; PRKCB1; PKCB; PKC-...</td>\n",
       "      <td>Plays a key role in B-cell activation by regul...</td>\n",
       "      <td>Kinase</td>\n",
       "      <td>MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQ...</td>\n",
       "      <td>Malignant haematopoietic neoplasm</td>\n",
       "      <td>P05771</td>\n",
       "      <td>Phase 3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>134485</th>\n",
       "      <td>3288</td>\n",
       "      <td>T68251</td>\n",
       "      <td>D00UCC</td>\n",
       "      <td>Small molecular drug</td>\n",
       "      <td>Discontinued in Phase 1</td>\n",
       "      <td>ABT-518</td>\n",
       "      <td>9827497</td>\n",
       "      <td>Solid tumour/cancer</td>\n",
       "      <td>Discontinued in Phase 1</td>\n",
       "      <td>MMP2_HUMAN</td>\n",
       "      <td>Matrix metalloproteinase-2 (MMP-2)</td>\n",
       "      <td>MMP2</td>\n",
       "      <td>TBE-1; Matrix metalloproteinase 2; CLG4A; 72 k...</td>\n",
       "      <td>As well as degrading extracellular matrix prot...</td>\n",
       "      <td>Peptidase</td>\n",
       "      <td>MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTD...</td>\n",
       "      <td>Multiple sclerosis</td>\n",
       "      <td>P08253</td>\n",
       "      <td>Terminated</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>134486 rows × 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "            ID TargetID  DRUGID              DRUGTYPE  \\\n",
       "0       140736   T51115  D0L4YD  Small molecular drug   \n",
       "1       133048   T60529  D03NMM  Small molecular drug   \n",
       "2        60493   T80975  D0T2ER  Small molecular drug   \n",
       "3       169176   T92072  D07ESH  Small molecular drug   \n",
       "4       120183   T30082  D0Q0RC  Small molecular drug   \n",
       "...        ...      ...     ...                   ...   \n",
       "134481  147910   T59328  D06WRF  Small molecular drug   \n",
       "134482   37688   T65236  D0WM5O  Small molecular drug   \n",
       "134483   30073   T47768  D04JHN  Small molecular drug   \n",
       "134484   37855   T40276  D0O0LS  Small molecular drug   \n",
       "134485    3288   T68251  D00UCC  Small molecular drug   \n",
       "\n",
       "               Drug_high_status       DRUGNAME  PUBCHCID  \\\n",
       "0                      Approved    Solifenacin    154059   \n",
       "1                 Investigative         AM-643  46843035   \n",
       "2                       Phase 1        TAK-593  24767976   \n",
       "3       Discontinued in Phase 3     PF-1913539    176408   \n",
       "4                      Approved  Ethopropazine      3290   \n",
       "...                         ...            ...       ...   \n",
       "134481                  Phase 2          KD019  10458325   \n",
       "134482                Phase 1/2             G1   5322399   \n",
       "134483                 Approved  Hydromorphone   5284570   \n",
       "134484                 Approved    Entrectinib  25141092   \n",
       "134485  Discontinued in Phase 1        ABT-518   9827497   \n",
       "\n",
       "                   Disease_of_highest_status              Drug_Status  \\\n",
       "0                         Overactive bladder                 Approved   \n",
       "1                     Dermatological disease            Investigative   \n",
       "2                        Solid tumour/cancer                  Phase 1   \n",
       "3                          Alzheimer disease  Discontinued in Phase 3   \n",
       "4                          Parkinson disease                 Approved   \n",
       "...                                      ...                      ...   \n",
       "134481                 Meningioma metastases                  Phase 2   \n",
       "134482                              Lymphoma                Phase 1/2   \n",
       "134483                          Chronic pain                  Phase 3   \n",
       "134484  Mammary analogue secretory carcinoma                  Phase 1   \n",
       "134485                   Solid tumour/cancer  Discontinued in Phase 1   \n",
       "\n",
       "           UNIPROID                                           TARGNAME  \\\n",
       "0       CAC1C_HUMAN  Voltage-gated calcium channel alpha Cav1.2 (CA...   \n",
       "1        PGH1_HUMAN               Prostaglandin G/H synthase 1 (COX-1)   \n",
       "2       VGFR2_HUMAN  Vascular endothelial growth factor receptor 2 ...   \n",
       "3        AA1R_HUMAN                     Adenosine A1 receptor (ADORA1)   \n",
       "4        ACES_HUMAN                        Acetylcholinesterase (AChE)   \n",
       "...             ...                                                ...   \n",
       "134481   EGFR_HUMAN            Epidermal growth factor receptor (EGFR)   \n",
       "134482  GPER1_HUMAN      G-protein coupled estrogen receptor 1 (GPER1)   \n",
       "134483   OPRM_HUMAN                           Opioid receptor mu (MOP)   \n",
       "134484   KPCB_HUMAN                      Protein kinase C beta (PRKCB)   \n",
       "134485   MMP2_HUMAN                 Matrix metalloproteinase-2 (MMP-2)   \n",
       "\n",
       "       GENENAME                                           SYNONYMS  \\\n",
       "0       CACNA1C  Voltage-gated calcium channel subunit alpha Ca...   \n",
       "1         PTGS1  Prostaglandin-endoperoxide synthase 1; Prostag...   \n",
       "2           KDR  VEGFR2; VEGFR-2; VEGF-2 receptor; Protein-tyro...   \n",
       "3        ADORA1     Adenosine receptor A1; A(1) adenosine receptor   \n",
       "4          ACHE                                 YT; N-ACHE; ARACHE   \n",
       "...         ...                                                ...   \n",
       "134481     EGFR  Receptor tyrosine-protein kinase erbB-1; Proto...   \n",
       "134482    GPER1  Membrane estrogen receptor; Lymphocyte-derived...   \n",
       "134483    OPRM1  hMOP; Mu-type opioid receptor; Mu opioid recep...   \n",
       "134484    PRKCB  Protein kinase C beta type; PRKCB1; PKCB; PKC-...   \n",
       "134485     MMP2  TBE-1; Matrix metalloproteinase 2; CLG4A; 72 k...   \n",
       "\n",
       "                                                 FUNCTION  \\\n",
       "0       Mediates influx of calcium ions into the cytop...   \n",
       "1       Converts arachidonate to prostaglandin H2 (PGH...   \n",
       "2       Plays an essential role in the regulation of a...   \n",
       "3       The activity of this receptor is mediated by G...   \n",
       "4       Role in neuronal apoptosis. Terminates signal ...   \n",
       "...                                                   ...   \n",
       "134481  Receptor tyrosine kinase binding ligands of th...   \n",
       "134482                           Receptor for estrogen. .   \n",
       "134483  Receptor for natural and synthetic opioids inc...   \n",
       "134484  Plays a key role in B-cell activation by regul...   \n",
       "134485  As well as degrading extracellular matrix prot...   \n",
       "\n",
       "                                  BIOCLASS  \\\n",
       "0                Voltage-gated ion channel   \n",
       "1       Paired donor oxygen oxidoreductase   \n",
       "2                                   Kinase   \n",
       "3                           GPCR rhodopsin   \n",
       "4               Carboxylic ester hydrolase   \n",
       "...                                    ...   \n",
       "134481                              Kinase   \n",
       "134482                      GPCR rhodopsin   \n",
       "134483                      GPCR rhodopsin   \n",
       "134484                              Kinase   \n",
       "134485                           Peptidase   \n",
       "\n",
       "                                                 SEQUENCE  \\\n",
       "0       MVNENTRMYIPEENHQGSNYGSPRPAHANMNANAAAGLAPEHIPTP...   \n",
       "1       MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGIC...   \n",
       "2       MQSKVLLAVALWLCVETRAASVGLPSVSLDLPRLSIQKDILTIKAN...   \n",
       "3       MPPSISAFQAAYIGIEVLIALVSVPGNVLVIWAVKVNQALRDATFC...   \n",
       "4       MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGG...   \n",
       "...                                                   ...   \n",
       "134481  MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFED...   \n",
       "134482  MDVTSQARGVGLEMYPGTAQPAAPNTTSPELNLSHPLLGTALANGT...   \n",
       "134483  MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCG...   \n",
       "134484  MADPAAGPPPSEGEESTVRFARKGALRQKNVHEVKNHKFTARFFKQ...   \n",
       "134485  MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTD...   \n",
       "\n",
       "                                    Disease Accession Number  Target_Status  \n",
       "0                Genetic cardiac arrhythmia           Q13936     Terminated  \n",
       "1                      Rheumatoid arthritis           P23219       Approved  \n",
       "2                      Renal cell carcinoma           P35968       Approved  \n",
       "3                    Hyper-lipoproteinaemia           P30542        Phase 2  \n",
       "4       Oesophageal/gastroduodenal disorder           P22303       Approved  \n",
       "...                                     ...              ...            ...  \n",
       "134481                         Chronic pain           P00533        Phase 2  \n",
       "134482                             Lymphoma           Q99527      Phase 1/2  \n",
       "134483                    Movement disorder           P35372  Investigative  \n",
       "134484    Malignant haematopoietic neoplasm           P05771        Phase 3  \n",
       "134485                   Multiple sclerosis           P08253     Terminated  \n",
       "\n",
       "[134486 rows x 19 columns]"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [],
   "source": [
    "train1_df.drop(columns=['ID','TargetID','DRUGID','PUBCHCID','SEQUENCE','Accession Number','SYNONYMS'],inplace =True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "701"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.TARGNAME.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "701"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.SYNONYMS.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "698"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.UNIPROID.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>ID</th>\n",
       "      <th>PUBCHCID</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>count</th>\n",
       "      <td>134486.000000</td>\n",
       "      <td>1.344860e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>95958.384107</td>\n",
       "      <td>1.397308e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>55524.645340</td>\n",
       "      <td>2.561885e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>2.000000</td>\n",
       "      <td>1.190000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>47764.250000</td>\n",
       "      <td>5.484100e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>96015.500000</td>\n",
       "      <td>5.280980e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>144131.750000</td>\n",
       "      <td>1.165886e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>192122.000000</td>\n",
       "      <td>1.357437e+08</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  ID      PUBCHCID\n",
       "count  134486.000000  1.344860e+05\n",
       "mean    95958.384107  1.397308e+07\n",
       "std     55524.645340  2.561885e+07\n",
       "min         2.000000  1.190000e+02\n",
       "25%     47764.250000  5.484100e+04\n",
       "50%     96015.500000  5.280980e+06\n",
       "75%    144131.750000  1.165886e+07\n",
       "max    192122.000000  1.357437e+08"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "2443"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.DRUGNAME.nunique()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(134486, 12)"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train1_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.model_selection import "
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.4"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
